The main objective of this prospective, controlled clinical study is: 1. To compare the treatment effects of PowerScope2 and Forsus Fatigue Resistant Device in patients with Class II divison1 malocclusion. 2. To compare the treatment effects of PowerScope2 and Forsus Fatigue Resistant Device with the control group. The null hypothesis for this study is that Forsus and PowerScope2 are equally effective in the treatment of ClassII div1 malocclusion.
Age range
12 Years – 17 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
mandibular length
Timeframe: 20 months
oropharyngeal volume
Timeframe: 20 months
condylar changes
Timeframe: 20 months
patient experiences
Timeframe: 20 months
pancherz analysis
Timeframe: 20 months
soft tissue changes
Timeframe: 20 months